$Tevogen Bio Holdings (TVGN.US)$ On Thursday, Tevogen Bio Ho...

$Tevogen Bio Holdings (TVGN.US)$ On Thursday, Tevogen Bio Holdings Inc. (NASDAQ stock code: TVGN) announced revenue forecasts for its oncology product line, with expected annual revenue of $1 billion on the market and an estimated accumulative total between $10 billion and $14 billion over 5 years. The company stated: "This forecast reflects the company's unique, faster, and cost-effective drug development model, which could serve as a blueprint to ensure sustainable medical innovation in the coming years."